WASHINGTON, D.C. – The U.S. Department of Health and Human Services (HHS) has finalized a rule that will expand patient and provider access to real-time prescription drug price information starting October 1.

The rule requires certified health information technology systems to support electronic prior authorization submissions, allow prescribers to see drug prices and insurance coverage details during patient visits, and enable electronic exchange of prescription information with pharmacies and insurers.

According to HHS, the change is intended to reduce administrative delays, provide patients with clearer cost information, and help physicians select treatment options covered by insurance. Officials said the policy builds on prior efforts from the Centers for Medicare & Medicaid Services (CMS) to improve interoperability and cut paperwork.

The announcement follows a June meeting between HHS leadership, CMS officials, and health insurers, where companies representing the majority of insured Americans agreed to implement reforms aimed at easing prior authorization requirements and increasing transparency.

Federal health leaders stated the rule could accelerate care decisions, improve workflow efficiency, and save costs by reducing time spent on paperwork. They also emphasized its role in ensuring patients have greater visibility into prescription options under Medicare, Medicaid, and commercial plans.

The final rule was developed through the HHS Office of the National Coordinator for Health Information Technology (ONC) in collaboration with CMS.